Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2021

01-05-2021 | Obesity

Effects of body composition on the procoagulant imbalance in obese patients

Authors: M. Candeloro, M. Di Nisio, E. Valeriani, R. Auciello, S. La Barba, M. T. Guagnano, D. Caniglia, C. Schiavone, M. D. Guglielmi, E. Porreca

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2021

Login to get access

Abstract

Obesity is associated with increased thrombotic risk and hypercoagulability whose main driver is an excess of coagulation factor VIII relative to protein C. The aims of this study were to evaluate the association between factor VIII, protein C, factor VIII-to-protein C ratio and bioimpedance parameters of body composition in obese patients. We analysed blood from 69 obese patients and 23 non-obese healthy controls. Plasma levels of factor VIII, protein C, and factor VIII-to-protein C ratio were correlated with total fat, visceral fat, and muscle mass. Compared to controls, obese patients had significantly higher factor VIII (110.5% vs 78.05%, p < 0.001), protein C (120.99% versus 110.51%, p = 0.014), and factor VIII-to-protein C ratio (0.93 versus 0.73, p = 0.002). In obese patients, factor VIII correlated with body-mass index, body fat percentage, muscle mass percentage, and fat-to-muscle ratio, whereas protein C had significant relationships with body fat percentage, muscle mass percentage and fat-to-muscle ratio, but not with body-mass index. Factor VIII-to-protein C ratio > 1 was significantly associated with body-mass index (odds ratio 1.08, 95% CI 1.02 to 1.14) and fat-to-muscle ratio (odds ratio 2.47, 95% CI 1.10 to 5.55). Factor VIII-to-protein C ratio strongly correlated with D-dimer levels in the overall population (rho 0.44, p < 0.001) and obese patients (rho 0.41, p < 0.001). In obese patients, bioimpedance measures of body fat and muscle mass percentage were associated with factor VIII and protein C. Factor VIII-to-protein C ratio was strongly associated with fat-to-muscle ratio and only modestly related to BMI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ogden CL, Carroll MD, Kit BK, Felgal KM, Ogden CL, Carroll MD, Kit BK, Flegal M (2016) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814CrossRef Ogden CL, Carroll MD, Kit BK, Felgal KM, Ogden CL, Carroll MD, Kit BK, Flegal M (2016) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814CrossRef
3.
go back to reference Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117(1):93–102CrossRef Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117(1):93–102CrossRef
4.
go back to reference Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377(1):13–27CrossRef Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377(1):13–27CrossRef
5.
go back to reference Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122(20):3415–3422CrossRef Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122(20):3415–3422CrossRef
6.
go back to reference Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K (2009) Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 120(19):1850–1857CrossRef Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K (2009) Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 120(19):1850–1857CrossRef
8.
go back to reference Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S et al (2019) Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol 4(2):163–173CrossRef Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S et al (2019) Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol 4(2):163–173CrossRef
10.
go back to reference Lowe GDO (2005) Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3(8):1618–1627CrossRef Lowe GDO (2005) Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3(8):1618–1627CrossRef
11.
go back to reference O’Donnell J, Mumford AD, Manning RA, Laffan MA (2001) Marked elevation of thrombin generation in patients with elevated FVIII: C and venous thromboembolism. Br J Haematol 115(3):687–691CrossRef O’Donnell J, Mumford AD, Manning RA, Laffan MA (2001) Marked elevation of thrombin generation in patients with elevated FVIII: C and venous thromboembolism. Br J Haematol 115(3):687–691CrossRef
12.
go back to reference Dahlbäck B (2004) Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol 79(2):109–116CrossRef Dahlbäck B (2004) Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol 79(2):109–116CrossRef
13.
go back to reference Tripodi A, Primignani M, Badiali S, de Ruberto F, Granelli P, Tosetti G et al (2019) Body mass index reduction improves the baseline procoagulant imbalance of obese subjects. J Thromb Thrombolysis 48(1):52–60CrossRef Tripodi A, Primignani M, Badiali S, de Ruberto F, Granelli P, Tosetti G et al (2019) Body mass index reduction improves the baseline procoagulant imbalance of obese subjects. J Thromb Thrombolysis 48(1):52–60CrossRef
14.
go back to reference Physical status: the use and interpretation of anthropometry (1995) Report of a WHO Expert Committee. vol 854, World Health Organization technical report series, pp 1–452. Physical status: the use and interpretation of anthropometry (1995) Report of a WHO Expert Committee. vol 854, World Health Organization technical report series, pp 1–452.
15.
go back to reference Schiavone C, Piscaglia F, Iannetti G, Cantisani V (2019) What ultrasound operators must be well aware of in a world with raising burden of non alcoholic fatty liver disease? Ultraschall Med 40(1):7–10CrossRef Schiavone C, Piscaglia F, Iannetti G, Cantisani V (2019) What ultrasound operators must be well aware of in a world with raising burden of non alcoholic fatty liver disease? Ultraschall Med 40(1):7–10CrossRef
16.
go back to reference Kyle UG, Bosaeus I, de Lorenzo AD, Deurenberg P, Elia M, Gómez JM et al (2004) Bioelectrical impedance analysis—Part I: review of principles and methods. Clin Nutr 23(5):1226–1243CrossRef Kyle UG, Bosaeus I, de Lorenzo AD, Deurenberg P, Elia M, Gómez JM et al (2004) Bioelectrical impedance analysis—Part I: review of principles and methods. Clin Nutr 23(5):1226–1243CrossRef
17.
go back to reference Tripodi A, Fracanzani AL, Primignani M, Chantarangkul V, Clerici M, Mannucci PM et al (2014) Procoagulant imbalance in patients with non-alcoholic fatty liver disease. J Hepatol 61(1):148–154CrossRef Tripodi A, Fracanzani AL, Primignani M, Chantarangkul V, Clerici M, Mannucci PM et al (2014) Procoagulant imbalance in patients with non-alcoholic fatty liver disease. J Hepatol 61(1):148–154CrossRef
18.
19.
go back to reference Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J et al (2008) Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32(6):959–966CrossRef Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J et al (2008) Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32(6):959–966CrossRef
20.
go back to reference Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117(6):241–250CrossRef Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117(6):241–250CrossRef
21.
go back to reference Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic steatohepatitis: a review. J Am Med Assoc 323(12):1175–1183CrossRef Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic steatohepatitis: a review. J Am Med Assoc 323(12):1175–1183CrossRef
22.
go back to reference Patil AG, Bihari C, Shewade HD, Nigam N, Sarin SK (2018) Decreased protein C function predicts mortality in patients with cirrhosis. Int J Lab Hematol 40(4):466–472CrossRef Patil AG, Bihari C, Shewade HD, Nigam N, Sarin SK (2018) Decreased protein C function predicts mortality in patients with cirrhosis. Int J Lab Hematol 40(4):466–472CrossRef
Metadata
Title
Effects of body composition on the procoagulant imbalance in obese patients
Authors
M. Candeloro
M. Di Nisio
E. Valeriani
R. Auciello
S. La Barba
M. T. Guagnano
D. Caniglia
C. Schiavone
M. D. Guglielmi
E. Porreca
Publication date
01-05-2021
Publisher
Springer US
Keywords
Obesity
Obesity
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02287-1

Other articles of this Issue 4/2021

Journal of Thrombosis and Thrombolysis 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.